Hepatitis B vaccination for newborns after surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the timing and safety of hepatitis B vaccination in term neonates who have undergone staged gastrointestinal surgery. The research aims to address the lack of consensus and guidelines regarding vaccination practices for these infants, as current approaches vary significantly among healthcare providers. By following a cohort of eligible newborns over a six-year period, the study will evaluate vaccination reactions and potential complications, providing valuable insights into optimal vaccination timing post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1\. Term neonates; 2. Underwent staged gastrointestinal surgery; 3. HBsAg-; 4. No immune system disease; 5.no serious defect of heart, brain, liver, kidney and other organs.

Exclusion Criteria:

1\. Premature; 2. HBsAg+; 3. Having immune system diseases; 4. Having serious defect of heart, brain, liver, kidney and other organs; 5. Lost patients.

Where it's running

• Children's Hospital of Chongqing Medical University
  Chongqing, Chongqing Municipality, China Recruiting

Study contacts

• Principal investigator: Hanbin Zhao, Doctor — Children's Hospital of Chongqing Medical University
• Study coordinator: Hanbin Zhao, Doctor
• Email: ddxek1994@outlook.com
• Phone: 18883370996

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Timing of hip fracture surgery for patients on DOAC blood thinners

  This project will see if operating within 24 hours is as safe as delaying surgery for people with hip fractures who recently took DOAC blood thinners by comparing how often they need blood transfusions.

  Recruiting at 7 sites St. Antonius Hospital · Almelo and 6 other locations · NCT07309848

• Germinal center immune response in chronic hepatitis B

  We will see if the structure and B-cell activity in germinal centers differ between people with chronic hepatitis B and people without by analyzing blood and discarded surgical tissues.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07240350

• GIGA-2339: safety and drug behavior testing in people with chronic hepatitis B

  This trial tests single and multiple IV doses of GIGA-2339 versus placebo to see if they are safe and well tolerated in adults with chronic hepatitis B.

  Recruiting at 19 sites Phase 1 GigaGen, Inc. · Chandler, Arizona and 19 other locations · NCT07024641

• Evaluating autologous blood transfusion in spinal surgery for lung cancer with spinal metastasis

  This study is testing whether using a patient's own blood during spinal surgery for lung cancer with spinal metastases is safer and more effective than using donated blood.

  Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT06244264

• Using a blood warmer to prevent hypothermia in preterm infants during blood transfusions

  This study is testing if using a blood warmer during blood transfusions can help very preterm infants stay warm and avoid hypothermia.

  Recruiting University of South Carolina · Columbia, South Carolina · NCT05170633

• Registry for patients with hepatitis B virus infection

  This study is collecting information from people with hepatitis B to better understand the virus and find out who might be interested in trying new treatments like vaccines.

  Recruiting Hannover Medical School · Hanover · NCT05051098

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.